UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration

Cousins, KAQ; Phillips, JS; Irwin, DJ; Lee, EB; Wolk, DA; Shaw, LM; Zetterberg, H; ... Grossman, M; + view all (2021) ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration. Alzheimer's & Dementia , 17 (5) pp. 822-830. 10.1002/alz.12233. Green open access

[thumbnail of Zetterberg_ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration_AAM.pdf]
Preview
Text
Zetterberg_ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration_AAM.pdf - Accepted Version

Download (1MB) | Preview

Abstract

INTRODUCTION: The ATN framework provides an in vivo diagnosis of Alzheimer's disease (AD) using cerebrospinal fluid (CSF) biomarkers of pathologic amyloid plaques (A), tangles (T), and neurodegeneration (N). ATN is rarely evaluated in pathologically confirmed patients and its poor sensitivity to suspected non-Alzheimer's pathophysiologies (SNAP), including frontotemporal lobar degeneration (FTLD), leads to misdiagnoses. We compared accuracy of ATN (ATNTAU ) using CSF total tau (t-tau) to a modified strategy (ATNNfL ) using CSF neurofilament light chain (NfL) in an autopsy cohort. METHODS: ATNTAU and ATNNfL were trained in an independent sample and validated in autopsy-confirmed AD (n = 67) and FTLD (n = 27). RESULTS: ATNNfL more accurately identified FTLD as SNAP (sensitivity = 0.93, specificity = 0.94) than ATNTAU (sensitivity = 0.44, specificity = 0.97), even in cases with co-occurring AD and FTLD. ATNNfL misclassified fewer AD and FTLD as "Normal" (2%) than ATNTAU (14%). DISCUSSION: ATNNfL is a promising diagnostic strategy that may accurately identify both AD and FTLD, even when pathologies co-occur.

Type: Article
Title: ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/alz.12233
Publisher version: https://doi.org/10.1002/alz.12233
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
Keywords: ATN, Alzheimer's disease, biomarkers, cerebrospinal fluid, frontotemporal degeneration, neurofilament light chain, suspected non-Alzheimer's pathophysiology, total tau
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10118879
Downloads since deposit
8,208Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item